Cytosolic microRNA-inducible nuclear translocation of Cas9 protein for disease-specific genome modification. Issue 10 (30th May 2022)

• Record Type: Journal Article
• Authors: Shin, Cheol-Hee; Park, Su Chan; Park, Il-Geun; Kim, Hyerim; An, Byoungha; Lee, Choongil; Kim, Sang-Heon; Lee, Juyong; Lee, Ji Min; Oh, Seung Ja
• Is Part Of: Nucleic acids research. Volume 50:Issue 10(2022)
• Page Start: 5919
• Page End: 5933
• Publication Date: 2022-05-30
• Subjects: Nucleic acids -- Periodicals; Molecular biology -- Periodicals; 572.805
• DOI: 10.1093/nar/gkac431
• Languages: English
• ISSNs: 0305-1048

Abstract

Abstract: MicroRNA-dependent mRNA decay plays an important role in gene silencing by facilitating posttranscriptional and translational repression. Inspired by this intrinsic nature of microRNA-mediated mRNA cleavage, here, we describe a microRNA-targeting mRNA as a switch platform called mRNA bridge mimetics to regulate the translocation of proteins. We applied the mRNA bridge mimetics platform to Cas9 protein to confer it the ability to translocate into the nucleus via cleavage of the nuclear export signal. This system performed programmed gene editing in vitro and in vivo . Combinatorial treatment with cisplatin and miR-21- EZH2 axis-targeting CRISPR Self Check-In improved sensitivity to chemotherapeutic drugs in vivo . Using the endogenous microRNA-mediated mRNA decay mechanism, our platform is able to remodel a cell's natural biology to allow the entry of precise drugs into the nucleus, devoid of non-specific translocation. The mRNA bridge mimetics strategy is promising for applications in which the reaction must be controlled via intracellular stimuli and modulates Cas9 proteins to ensure safe genome modification in diseased conditions.